Evidence map›Paper›PMID 36553468›Full record

ArticleGenes2022

Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing.

Xu Liu, Heming Ma, Ruihong Wu, Huan Wang, Hongqin Xu, Shuxuan Li, Guangyi Wang, Guoyue Lv, Junqi Niu

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xu LiuDepartment of Hepatology, First Hospital of Jilin University, Changchun 130021, China.
Heming MaDepartment of Hepatology, First Hospital of Jilin University, Changchun 130021, China.
Ruihong WuDepartment of Hepatology, First Hospital of Jilin University, Changchun 130021, China.
Huan WangDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Hongqin XuDepartment of Hepatology, First Hospital of Jilin University, Changchun 130021, China.
Shuxuan LiDepartment of Hepatobiliary and Pancreatic Surgery, First Hospital of Jilin University, Changchun 130021, China.
Guangyi WangDepartment of Hepatobiliary and Pancreatic Surgery, First Hospital of Jilin University, Changchun 130021, China.
Guoyue LvDepartment of Hepatobiliary and Pancreatic Surgery, First Hospital of Jilin University, Changchun 130021, China.
Junqi NiuDepartment of Hepatology, First Hospital of Jilin University, Changchun 130021, China.
First Hospital of Jilin University · CNJilin University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) participate in hepatic stellate cell (HSC) activation, which drives liver fibrosis initiation and progression. We aimed to identify novel hepatic fibrosis targets using miRNA sequencing (miRNA-seq) of human primary HSCs. Surgically resected liver tissues were used to extract HSCs. Based on next-generation sequencing, miRNA-seq was performed on four pairs of HSCs before and after in vitro culture. Additionally, we compared our data with open access miRNA-seq data derived from fourteen cirrhotic and nine healthy liver tissues. Selected miRNAs associated with fibrosis were verified by quantitative real-time PCR. Target mRNAs of differentially expressed (DE) miRNAs were predicted to construct co-expression networks. We identified 230 DEmiRNAs (118 upregulated and 112 downregulated) upon HSC activation. Of the 17 miRNAs with the most significant differences in expression, liver disease-related miRNAs included

Indexed as

MicroRNAsHepatic Stellate CellsHigh-Throughput Nucleotide SequencingHumansLiver CirrhosisMicroRNAsMIRN139 microRNA, humanMIRN340 microRNA, humanMIRN381 microRNA, humanMIRN493 microRNA, humanMIRN665 microRNA, humanMIRN758 microRNA, humanhuman primary hepatic stellate cellliver fibrosismicroRNAnext-generation sequencingtarget

Identifiers

PMID36553468
PMCPMC9778123
OpenAlexW4309848515

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.